Physician

Brian Cervenka, M.D.

According to 2025 Medicare claims, Brian Cervenka, M.D. (NPI: 1710327358) practices otolaryngology in the Greeley, CO market, with the plurality of this provider's patient population coming from Weld, CO. This provider's primary affiliated billing organization is UNIVERSITY PHYSICIANS INCORPORATED (NPI: 1962461889; TIN: 742161737) and primary practice location at 80045-2545. Cervenka is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Cervenka's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 182 traditional Medicare patients, billed 539 HCPCS/CPT codes, and received $115,886 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 67 prescription claims across 28 beneficiaries totaling $1,480 in drug costs, led by Lidocaine Hcl Viscous (Lidocaine Hcl). DME data shows 28 claims. Open Payments data shows 2 records totaling $247. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $21,379 to $115,886. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $4,483 and ending at $1,480. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	65	139	$21,379
2020	134	446	$81,922
2021	169	644	$88,559
2022	130	325	$68,989
2023	154	480	$106,138
2024	182	539	$115,886

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	47	71	$4,483
2016	64	132	$3,731
2017	48	84	$2,616
2018	23	41	$881
2019	N/R	N/R	N/R
2020	29	75	$1,215
2021	45	116	$11,199
2022	28	44	$778
2023	15	29	$1,667
2024	28	67	$1,480

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	12	$2,622
2021	N/R	66	$7,960
2022	N/R	29	$5,446
2023	N/R	46	$4,568
2024	N/R	28	$3,295

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	54	54	$138
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	49	55	$76
10005	Fine needle aspiration biopsy using ultrasound guidance, first growth	24	27	$54
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	51	69	$48
31575	Diagnostic exam of voice box using a flexible endoscope	59	81	$47

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lidocaine Hcl Viscous	Lidocaine Hcl	12	24	$124

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	17	$2,012
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	11	$1,283

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$247	Zimmer Biomet Holdings, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brian Cervenka, M.D.?

Tedicare shows public-source Medicare data for Brian Cervenka, M.D. (NPI 1710327358), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brian Cervenka, M.D. have ACO affiliation data?

Brian Cervenka, M.D. is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Brian Cervenka, M.D.?

Brian Cervenka, M.D. is linked to UNIVERSITY PHYSICIANS INCORPORATED (billing NPI 1962461889) in the available physician profile data.

Does Brian Cervenka, M.D. have Open Payments data?

Brian Cervenka, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.